SureTrader Nadex Advertisement
Home > Boards > US Listed > Medical - Drugs >

Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

Add KTOV Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/16/2017 11:32:50 AM - Followers: 124 - Board type: Free - Posts Today: 0



US Office

1615 Suter’s Lane NW, Washington DC 20007, Tel:  +1-202-965-2215

Israel Office

One Azrieli Center, Round Tower, Tel Aviv 6701101


Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs
that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Kitov is developing combination drug products that treat the pain of osteoarthritis without causing cardiovascular problems.
These drugs will not only not need to be labeled with health warnings, but will actually be labeled as reducing the risk of
cardiovascular events. Kitov’s drugs have the potential to improve the health of millions of patients worldwide.
It is expected that physicians will prefer to prescribe them rather than prescribe two separate drugs, to improve their patients’ health and to reduce their own legal exposure.

Kitov is currently focusing two late-stage drugs. Both contain NSAIDs that are widely consumed throughout the world for treating osteoarthritis.
Each of Kitov’s drugs adds to the NSAID a second drug product that reduces hypertension.

KIT-301: Naproxen combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled
for 20-24 months from start of development.
KIT-302: Celecoxib combined with anti-hypertension. Ready for phase III clinical trial. New Drug Application (NDA) scheduled for 2015.

Osteoarthritis, affecting approximately half of all adults over the age of 50, is a degenerative disease of joints that can cause pain and limit mobility.
Exercise and weight control are important therapies for controlling symptoms, but for many patients medication is the next step in pain treatment.
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used medications for treating osteoarthritis pain.
However, these medications raise blood pressure (hypertension) and thereby increase the risk of heart attacks, strokes, and death.
This has led the US FDA to require including a black box warning in the labeling of all NSAIDs, warning of these increased cardiovascular risks.


Dr. John Paul Waymack – M.D., Sc.D.

Chairman of the Board of Directors and Chief Medical Officer

Dr. Waymack was one of the founders of Kitov Pharmaceuticals and has served as the Chairman of our Board of Directors and Chief Medical Officer since July 2013. Dr. Waymack has over 20 years of experience in the biopharma field. Dr. Waymack is a former academic transplant surgeon and a former FDA medical officer, with over fifteen years of experience in drug development as a consultant to major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10 years of academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. In addition, Dr. Waymack volunteered to the U.S. army, where he was commissioned and served as a Major in the Medical Corp. in the position of Chief of Surgical Research in the U.S. Army’s Institute for Surgical Research. Dr. Waymack was also an associate professor of surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey.



Dec. 17, 2015 :  Kitov Pharmaceuticals Reports Additional Data from its Phase III Trial on the Beneficial Blood Pressure Effects of KIT-302

November 20, 2015 : Kitov Pharmaceuticals Holdings Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing

October 21, 2015 : Kitov Pharma Announces Completion of Patient Recruitment for the Phase III Clinical Trial for KIT-302


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
KTOV News: Report of Foreign Issuer (6-k) 02/16/2017 04:47:51 PM
KTOV News: Report of Foreign Issuer (6-k) 02/10/2017 02:25:55 PM
KTOV News: Report of Foreign Issuer (6-k) 02/09/2017 04:26:06 PM
KTOV News: Nasdaq Scheduled Resumption in Kitov Pharmaceuticals Holdings Ltd. 02/09/2017 10:20:31 AM
KTOV News: Report of Foreign Issuer (6-k) 02/07/2017 05:12:05 PM
#5400   Thanks for the insight. At the very least LittleBytor 02/16/17 11:32:50 AM
#5399   For sure, I've developed a sense of humor rnoutlaw21 02/15/17 10:35:02 PM
#5398   I've been in bio's 5 years or so tmeier 02/15/17 08:42:25 PM
#5397   Agree, will just have to let this RBNEWS 02/15/17 01:28:09 PM
#5396   You can see the complaint on runninggirl2017 02/15/17 01:26:20 PM
#5395   can you share more? ylama3 02/15/17 01:20:12 PM
#5394   I do find that interesting. I also runninggirl2017 02/15/17 01:17:26 PM
#5393   Bingo, thanks for pulling that info. Very Strange RBNEWS 02/15/17 01:04:42 PM
#5392   That's a good point this is the item ylama3 02/15/17 01:03:07 PM
#5391   Thank you. I've just heard so many negative LittleBytor 02/15/17 12:37:01 PM
#5390   IMO, we are dealing with an RBNEWS 02/15/17 12:34:56 PM
#5389   I now believe the issues were financial misstatements/ runninggirl2017 02/15/17 12:02:15 PM
#5388   I believe Kitov products still stand as they are. Doubletree 02/15/17 11:25:10 AM
#5387   Yes,it's called an NDA, Partnership deal for the tmeier 02/15/17 11:20:27 AM
#5386   Hey all, is there any hope in this LittleBytor 02/15/17 11:07:37 AM
#5385   It costs millions in fees to submit an rnoutlaw21 02/14/17 09:39:38 PM
#5384   Perhaps. Let's see if they follow through nsomniyak 02/14/17 07:16:56 PM
#5383   I agree, by pure luck I exited due westeffer 02/14/17 06:31:17 PM
#5382   IMO warrants are dead here. The picture really rocketeer357 02/14/17 06:25:35 PM
#5381   We are still looking for details, however I nsomniyak 02/14/17 09:25:45 AM
#5380   Little Confused on Investigation. focus2011 02/14/17 05:36:25 AM
#5379   Exactly notes in Tyrnovo, not Kitov. Anyway it looks EM 02/10/17 01:25:53 PM
#5378   I think it's more the role of the runninggirl2017 02/10/17 01:06:10 PM
#5377   Overall I thought a good pr. I RBNEWS 02/10/17 12:59:53 PM
#5376   Crazy times! runninggirl2017 02/10/17 12:54:15 PM
#5375   Kitov Announces Settlement Agreement with Minority Shareholder of midastouch017 02/10/17 12:38:00 PM
#5374   New 6-K filed Normal trading resumes TASE next djpope 02/09/17 04:46:16 PM
#5373   Lawyers! runninggirl2017 02/09/17 01:39:41 PM
#5372   Mrs Israel: Issac, what happened and why ylama3 02/09/17 01:23:17 PM
#5371   I loaded more Ws @ .40 this morning BEANPOLE 02/09/17 12:02:52 PM
#5370   Nice!! tmeier 02/09/17 11:50:37 AM
#5369   Just bought more shares. Doubletree 02/09/17 11:47:15 AM
#5368   NDA reported to be Filed during Q1 2017. ash111 02/09/17 11:30:16 AM
#5367   Im staying out for now too, but nice RBNEWS 02/09/17 11:29:02 AM
#5366   It may be good news. I'm still out bigcat2 02/09/17 11:23:08 AM
#5365   not holding commons but hasn't changed my warrants ash111 02/09/17 10:52:49 AM
#5364   Time to get back in and load the boat!! tmeier 02/09/17 10:41:58 AM
#5363   Lmao this is the best possible news. salgovernale69 02/09/17 10:36:33 AM
#5362   Nasdaq Scheduled Resumption in Kitov Pharmaceuticals Holdings Ltd. midastouch017 02/09/17 10:32:57 AM
#5361   The opposite! DMC data was not so important EM 02/09/17 10:20:10 AM
#5360   I can tell you. This is absolutely bad news. DavidW2 02/09/17 10:13:41 AM
#5359   Kitov Says ISA Investigation Centered On DMC Associated midastouch017 02/09/17 09:54:16 AM
#5358   Can't disagree with that. runninggirl2017 02/09/17 09:51:38 AM
#5357   Excellent PR. Sounds like Waymack not saying runninggirl2017 02/09/17 09:51:17 AM
#5356   Not at all. All I'm saying is mikeonmicrocaps 02/09/17 09:36:27 AM
#5355   Kitov Provides Further Update on Formal Investigation by midastouch017 02/09/17 09:34:33 AM
#5354   Are you implying that the market knew or runninggirl2017 02/09/17 09:02:43 AM
#5353   If this is such a blockbuster drug combo, mikeonmicrocaps 02/09/17 08:43:03 AM
#5352   The good news better be that crook Issac tmeier 02/09/17 02:02:45 AM
#5351   Yep. Very weird. Maybe he got runninggirl2017 02/08/17 08:40:59 PM